Fritillaria cirrhosa, Anemarrhena asphodeloides, Lee-Mo-Tang and cyclosporine a inhibit ovalbumin-induced eosinophil accumulation and Th2-mediated bronchial hyperresponsiveness in a murine model of asthma

Basic and Clinical Pharmacology and Toxicology

Volumn 100, Issue 3, 2007, Pages 205-213

  Yeum, Hyun Shiek ^a   Lee, Young Cheol ^a   Kim, Seung Hyung ^b   Roh, Seong Soo ^b   Lee, Jang Cheon ^a   Seo, Young Bae ^b  

^a Department of Computer and Electronic Physics   (South Korea)

^b Daejeon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMARRHENA ASPHODELOIDES EXTRACT; CYCLOSPORIN A; CYTOKINE; FRITILLARIA CIRRHOSA EXTRACT; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LEE MO TANG; OVALBUMIN; PLANT EXTRACT; THYMIDINE; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANEMARRHENA ASPHODELOIDES; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL COUNT; FLUORESCENCE ACTIVATED CELL SORTER; FRITILLARIA CIRRHOSA; HISTAMINE RELEASE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; INTERFERON PRODUCTION; LEUKOCYTE MIGRATION INHIBITION; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MEDICINAL PLANT; NONHUMAN; ORIENTAL MEDICINE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH2 CELL; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANEMARRHENA; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROLIFERATION; CYCLOSPORINE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FLOW CYTOMETRY; FRITILLARIA; HISTAMINE; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKINS; LUNG; MALE; MEDICINE, HERBAL; MICE; OVALBUMIN; PHYTOTHERAPY; PLANT PREPARATIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANEMARRHENA; ANEMARRHENA ASPHODELOIDES; BULBUS; FRITILLARIA CIRRHOSA; MURINAE;

EID: 33847015212     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00043.x     Document Type: Article

References (18)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45.
2. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax 2002;57:643-8.
3. Phillip F. Gene therapy for asthma. Mol Ther 2003;7:148-52.
4. Jeong S-J, Higuchi R, Ono M, Kuwano M, Kim Y-C, Miyamoto T. cis-Hinokiresinol, a norlignan from Anemarrhena asphodeloides, inhibits angiogenic response in vitro and in vivo. Biol Pharm Bull 2003;26:1721-4.
5. Lin G, Li P, Li SL, Chan SW. Chromatographic analysis of Fritillaria isosteroidal alkaloids, the active ingredients of Beimu, the antitussive traditional Chinese medicinal herb. J Chromatogr A 2001;935:321-38.
6. Tanaka H, Masuda T, Tokuoka S et al. The effect of allergeninduced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm Res 2001;50:616-24.
7. Tanaka H, Kawada N, Yamada T, Kawada K, Takatsu K, Nakgai H. Allergen-induced airway inflammation and bronchial responsiveness in interleukin-5 receptor chain-deficient mice. Clin Exp Allergy 2000;30:874-81.
8. Lee JJ, McGarry MP, Farmer SC et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:2143-56.
9. Borchers MT, Crosby J, Farmer S et al. Blockade of CD49d inhibits allergic airway pathologies independent of effects on leukocyte recruitment. Am J Physiol Lung Cell Mol Physiol 2001;280:813-21.
10. Ohkawara Y, Lei XF, Stämpfli MR, Marshall JS, Xing Z, Jordana M. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Am J Respir Cell Mol Biol 1997;16:510-20.
11. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: relationship to bronchial hyperreactivity. Am Rev Respir Dis 1998;137:62-9.
12. Owen WF, Soberman RJ, Yoshimoto T, Sheffer AL, Lewis RA, Austen KF. Synthesis and release of leukotriene C4 by human eosinophils. J Immunol 1987;138:532-8.
13. Sergio R. T-cell responses in allergy and asthma. Curr Opin Allergy Clin Immunol 2001;1:73-8.
14. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophils and basophils recruitment. J Allergy Clin Immunol 1994;94:427-38.
15. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996;183:195.
16. Wang J, Palmer K, Lötvall J et al. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia. J Clin Invest 1998;102:1132-41.
17. Homer A, Boushey MD. New and exploratory therapies for asthma. Chest 2003;123:439-45.
18. Heath H, Qin S, Rao P et al. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997;99:178-84.